MEDICENNA THERAPEUTICS CORP (MDNA)
CA58490H1073 - Common Stock
| MRQ (2023-6-30) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 29.61M | 33.60M | 20.54M | 30.38M | 22.70M | |||
| Marketable Securities | N/A | N/A | 0.00 | 10.01M | 15.00M | |||
| Receivables | 835.00K | 855.00K | 1.31M | 410.00K | 60.00K | |||
| Other Current Assets | 1.04M | 1.93M | 1.55M | 1.35M | 90.00K | |||
| Total Current Assets | 31.49M | 36.38M | 23.39M | 42.15M | 37.85M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | 0.00 | 30.00K | 70.00K | |||
| Intangibles | 60.00K | 61.00K | 65.00K | 70.00K | 80.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 60.00K | 61.00K | 65.00K | 100.00K | 150.00K | |||
| TOTAL ASSETS | 31.55M | 36.45M | 23.46M | 42.25M | 38.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 30.00K | 40.00K | |||
| Accrued Expenses | N/A | 2.18M | 949.00K | 1.83M | 1.32M | |||
| Accounts Payable | 3.23M | 1.62M | 1.67M | 2.25M | 460.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 3.23M | 3.80M | 2.62M | 4.11M | 1.82M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 30.00K | |||
| Other Non-Current Liabilities | 1.41M | 3.16M | N/A | N/A | 0.00 | |||
| Total Non-Current Liabilities | 1.41M | 3.16M | 0.00 | 0.00 | 30.00K | |||
| TOTAL LIABILITIES | 4.65M | 6.96M | 2.62M | 4.11M | 1.85M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -83.84M | -80.98M | -70.93M | -48.36M | -31.07M | |||
| Additional Paid In Capital | 9.78M | 9.49M | 7.93M | 6.68M | 10.39M | |||
| Common Shares | 100.92M | 100.92M | 83.67M | 79.59M | 56.58M | |||
| Other Shareholders' Equity | 37.00K | 57.00K | 171.00K | 230.00K | 250.00K | |||
| Shares Outstanding | 69.64M | 69.64M | 55.65M | 53.55M | 46.80M | |||
| Tangible Book Value per Share | 0.39 | 0.42 | 0.37 | 0.71 | 0.77 | |||
| Total Shareholders' Equity | 26.90M | 29.49M | 20.84M | 38.15M | 36.15M | |||
| TOTAL LIABILITIES AND EQUITY | 31.55M | 36.45M | 23.46M | 42.25M | 38.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Current Ratio | 9.74 | 9.57 | 8.92 | 10.26 | 20.80 | |||
| Return On Assets (ROA) | -27.75% | -27.57% | -96.25% | -40.92% | -21.79% | |||
| Return On Equity (ROE) | -32.55% | -34.08% | -108.36% | -45.32% | -22.90% | |||
All data in CAD